Symbols / MBOT Stock $2.04 -2.86% Microbot Medical Inc.
MBOT (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
No company description available for this symbol.
Ratings
- Microbot Medical (NASDAQ: MBOT) outlines $39,230,691 at-the-market stock plan - Stock Titan Fri, 10 Apr 2026 07
- Microbot Medical Begins Full U.S. Launch of LIBERTY System - Yahoo Finance Wed, 15 Apr 2026 07
- Microbot Medical (MBOT) price target increased by 12.50% to 7.65 - MSN Wed, 29 Apr 2026 08
- Surgery Robot Stock Run Down: MBOT RBOT EKSO SSII ARAY SYK ISRG MDT ZBH BDX PRCT (EfG7qtkBHV) - Fathom Journal Sat, 25 Apr 2026 11
- MBOT Stock Falls As Investors Ponder Impact Of Geopolitical Tensions On Israel-Founded Company - Stocktwits hu, 05 Mar 2026 08
- Only FDA-cleared single-use endovascular robot expands U.S. rollout - Stock Titan Mon, 13 Apr 2026 07
- Here's Why We're Not Too Worried About Microbot Medical's (NASDAQ:MBOT) Cash Burn Situation - Yahoo Finance Sun, 07 Dec 2025 08
- Microbot’s LIBERTY robot heads for full US launch despite geopolitical events - Stock Titan ue, 03 Mar 2026 08
- Down 28.2% in 4 Weeks, Here's Why You Should You Buy the Dip in Microbot Medical (MBOT) - Yahoo Finance Wed, 29 Oct 2025 07
- Doctors face radiation and strain risks; Microbot sees a LIBERTY opening - Stock Titan Wed, 22 Apr 2026 12
- Remote vascular surgery robot nears full market release in April - Stock Titan ue, 17 Mar 2026 07
- Microbot Medical (NASDAQ: MBOT) to spotlight LIBERTY robotic system FMR - Stock Titan ue, 14 Apr 2026 07
- The only FDA-cleared single-use vascular robot just took center stage in Miami - Stock Titan hu, 12 Feb 2026 08
- Director at Microbot Medical (NASDAQ: MBOT) awarded 10,000 stock options at $2.37 strike - Stock Titan Fri, 03 Apr 2026 07
- Single-use surgery robot aiming to cut radiation gets investor spotlight - Stock Titan ue, 10 Mar 2026 07
Insider Transactions
No recent insider transactions.
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Expense |
|
14.74
+26.82%
|
11.62
+14.69%
|
10.14
-24.57%
|
13.44
|
| Research And Development |
|
6.28
-5.23%
|
6.63
+15.83%
|
5.72
-26.01%
|
7.74
|
| Selling General And Administration |
|
8.25
+67.59%
|
4.92
+13.99%
|
4.32
-22.65%
|
5.58
|
| General And Administrative Expense |
|
8.25
+67.59%
|
4.92
+13.99%
|
4.32
-22.65%
|
5.58
|
| Salaries And Wages |
|
4.57
+49.92%
|
3.05
+37.99%
|
2.21
-30.43%
|
3.18
|
| Other Gand A |
|
3.28
+129.69%
|
1.43
-14.18%
|
1.66
-0.36%
|
1.67
|
| Other Operating Expenses |
|
0.21
+187.84%
|
0.07
-22.11%
|
0.10
-20.83%
|
0.12
|
| Total Expenses |
|
14.74
+26.82%
|
11.62
+14.69%
|
10.14
-24.57%
|
13.44
|
| Operating Income |
|
-14.74
-26.82%
|
-11.62
-14.69%
|
-10.14
+24.57%
|
-13.44
|
| Total Operating Income As Reported |
|
-14.74
-26.82%
|
-11.62
-17.96%
|
-9.86
+25.80%
|
-13.28
|
| EBITDA |
|
-14.70
-27.41%
|
-11.53
-15.00%
|
-10.03
+24.78%
|
-13.34
|
| Normalized EBITDA |
|
-14.70
-27.41%
|
-11.53
-25.40%
|
-9.20
+32.12%
|
-13.55
|
| Reconciled Depreciation |
|
0.05
-48.35%
|
0.09
-14.15%
|
0.11
+3.92%
|
0.10
|
| EBIT |
|
-14.74
-26.82%
|
-11.62
-14.69%
|
-10.14
+24.57%
|
-13.44
|
| Total Unusual Items |
|
—
|
0.00
+100.00%
|
-0.83
-486.98%
|
0.21
|
| Total Unusual Items Excluding Goodwill |
|
—
|
0.00
+100.00%
|
-0.83
-486.98%
|
0.21
|
| Special Income Charges |
|
—
|
0.00
+100.00%
|
-0.83
-650.99%
|
0.15
|
| Other Special Charges |
|
—
|
—
|
0.83
+632.05%
|
-0.16
|
| Restructuring And Mergern Acquisition |
|
—
|
—
|
—
|
—
|
| Net Income |
|
-13.14
-14.85%
|
-11.44
-6.55%
|
-10.74
+18.44%
|
-13.17
|
| Pretax Income |
|
-13.14
-14.85%
|
-11.44
-6.55%
|
-10.74
+18.44%
|
-13.17
|
| Net Non Operating Interest Income Expense |
|
1.28
+606.04%
|
0.18
-20.18%
|
0.23
+322.22%
|
0.05
|
| Net Interest Income |
|
1.28
+606.04%
|
0.18
-20.18%
|
0.23
+322.22%
|
0.05
|
| Interest Income Non Operating |
|
—
|
—
|
0.28
+424.07%
|
0.05
|
| Interest Income |
|
—
|
—
|
0.28
+424.07%
|
0.05
|
| Other Income Expense |
|
0.32
|
—
|
-0.83
-486.98%
|
0.21
|
| Other Non Operating Income Expenses |
|
0.32
|
—
|
—
|
—
|
| Gain On Sale Of Security |
|
—
|
—
|
-0.06
-185.94%
|
0.06
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-13.14
-14.85%
|
-11.44
-6.55%
|
-10.74
+18.44%
|
-13.17
|
| Net Income From Continuing Operation Net Minority Interest |
|
-13.14
-14.85%
|
-11.44
-6.55%
|
-10.74
+18.44%
|
-13.17
|
| Net Income From Continuing And Discontinued Operation |
|
-13.14
-14.85%
|
-11.44
-6.55%
|
-10.74
+18.44%
|
-13.17
|
| Net Income Continuous Operations |
|
-13.14
-14.85%
|
-11.44
-6.55%
|
-10.74
+18.44%
|
-13.17
|
| Normalized Income |
|
-13.14
-14.85%
|
-11.44
-15.49%
|
-9.91
+25.97%
|
-13.38
|
| Net Income Common Stockholders |
|
-13.14
-14.85%
|
-11.44
-6.55%
|
-10.74
+18.44%
|
-13.17
|
| Diluted EPS |
|
-0.29
+60.27%
|
-0.73
+30.48%
|
-1.05
+41.99%
|
-1.81
|
| Basic EPS |
|
-0.29
+60.27%
|
-0.73
+30.48%
|
-1.05
+41.99%
|
-1.81
|
| Basic Average Shares |
|
45.79
+192.69%
|
15.64
+53.38%
|
10.20
+40.49%
|
7.26
|
| Diluted Average Shares |
|
45.79
+192.69%
|
15.64
+53.38%
|
10.20
+40.49%
|
7.26
|
| Diluted NI Availto Com Stockholders |
|
-13.14
-14.85%
|
-11.44
-6.55%
|
-10.74
+18.44%
|
-13.17
|
| Depreciation Amortization Depletion Income Statement |
|
—
|
—
|
—
|
—
|
| Depreciation And Amortization In Income Statement |
|
—
|
—
|
—
|
—
|
| Depreciation Income Statement |
|
—
|
—
|
—
|
—
|
| Gain On Sale Of PPE |
|
—
|
0.00
+100.00%
|
-0.00
+60.00%
|
-0.01
|
| Insurance And Claims |
|
0.39
-11.09%
|
0.44
+0.00%
|
0.44
-39.70%
|
0.73
|
| Total Other Finance Cost |
|
-1.28
-606.04%
|
-0.18
+20.18%
|
-0.23
|
—
|
| Line Item | Trend | 2023-12-31 |
|---|---|---|
| Total Assets |
|
8.33
|
| Current Assets |
|
7.92
|
| Cash Cash Equivalents And Short Term Investments |
|
6.38
|
| Cash And Cash Equivalents |
|
2.47
|
| Cash Equivalents |
|
0.00
|
| Cash Financial |
|
2.47
|
| Other Short Term Investments |
|
3.92
|
| Receivables |
|
1.49
|
| Other Receivables |
|
1.49
|
| Loans Receivable |
|
—
|
| Inventory |
|
—
|
| Raw Materials |
|
—
|
| Work In Process |
|
—
|
| Prepaid Assets |
|
—
|
| Restricted Cash |
|
0.05
|
| Total Non Current Assets |
|
0.41
|
| Net PPE |
|
0.41
|
| Gross PPE |
|
0.90
|
| Accumulated Depreciation |
|
-0.49
|
| Properties |
|
0.00
|
| Buildings And Improvements |
|
0.26
|
| Machinery Furniture Equipment |
|
0.41
|
| Other Properties |
|
—
|
| Leases |
|
0.23
|
| Non Current Prepaid Assets |
|
—
|
| Other Non Current Assets |
|
—
|
| Total Liabilities Net Minority Interest |
|
3.83
|
| Current Liabilities |
|
3.79
|
| Payables And Accrued Expenses |
|
2.79
|
| Payables |
|
0.36
|
| Accounts Payable |
|
0.36
|
| Current Accrued Expenses |
|
2.43
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
0.72
|
| Current Debt And Capital Lease Obligation |
|
0.19
|
| Current Capital Lease Obligation |
|
0.19
|
| Current Deferred Liabilities |
|
—
|
| Current Deferred Revenue |
|
—
|
| Other Current Liabilities |
|
0.08
|
| Total Non Current Liabilities Net Minority Interest |
|
0.04
|
| Long Term Debt And Capital Lease Obligation |
|
0.04
|
| Long Term Capital Lease Obligation |
|
0.04
|
| Stockholders Equity |
|
4.50
|
| Common Stock Equity |
|
4.50
|
| Capital Stock |
|
0.12
|
| Common Stock |
|
0.12
|
| Share Issued |
|
11.71
|
| Ordinary Shares Number |
|
11.71
|
| Treasury Shares Number |
|
0.00
|
| Additional Paid In Capital |
|
83.88
|
| Retained Earnings |
|
-79.50
|
| Total Equity Gross Minority Interest |
|
4.50
|
| Total Capitalization |
|
4.50
|
| Working Capital |
|
4.13
|
| Invested Capital |
|
4.50
|
| Total Debt |
|
0.23
|
| Capital Lease Obligations |
|
0.23
|
| Net Tangible Assets |
|
4.50
|
| Tangible Book Value |
|
4.50
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-13.05
-47.80%
|
-8.83
-3.45%
|
-8.53
+26.11%
|
-11.55
|
| Cash Flow From Continuing Operating Activities |
|
-13.05
-47.80%
|
-8.83
-3.45%
|
-8.53
+26.11%
|
-11.55
|
| Net Income From Continuing Operations |
|
-13.14
-14.85%
|
-11.44
-6.55%
|
-10.74
+18.44%
|
-13.17
|
| Depreciation Amortization Depletion |
|
0.05
-48.35%
|
0.09
-14.15%
|
0.11
+3.92%
|
0.10
|
| Depreciation |
|
0.05
-48.35%
|
0.09
-14.15%
|
0.11
+3.92%
|
0.10
|
| Depreciation And Amortization |
|
0.05
-48.35%
|
0.09
-14.15%
|
0.11
+3.92%
|
0.10
|
| Other Non Cash Items |
|
—
|
0.23
-67.32%
|
0.72
+6066.67%
|
-0.01
|
| Stock Based Compensation |
|
1.06
-21.65%
|
1.35
-3.23%
|
1.39
-20.43%
|
1.75
|
| Operating Gains Losses |
|
—
|
—
|
0.00
-60.00%
|
0.01
|
| Unrealized Gain Loss On Investment Securities |
|
—
|
—
|
—
|
-0.01
|
| Gain Loss On Sale Of PPE |
|
—
|
0.00
-100.00%
|
0.00
-60.00%
|
0.01
|
| Change In Working Capital |
|
-1.01
-207.01%
|
0.94
+8663.64%
|
-0.01
+95.18%
|
-0.23
|
| Change In Inventory |
|
-0.58
|
0.00
|
—
|
—
|
| Change In Prepaid Assets |
|
-0.92
-1431.88%
|
0.07
-89.73%
|
0.67
+5069.23%
|
0.01
|
| Change In Payables And Accrued Expense |
|
0.49
-43.30%
|
0.87
+227.82%
|
-0.68
-183.40%
|
-0.24
|
| Investing Cash Flow |
|
-72.38
-4809.43%
|
1.54
-22.10%
|
1.97
+151.43%
|
-3.84
|
| Cash Flow From Continuing Investing Activities |
|
-72.38
-4809.43%
|
1.54
-22.10%
|
1.97
+151.43%
|
-3.84
|
| Net PPE Purchase And Sale |
|
-0.06
-140.00%
|
-0.03
+24.24%
|
-0.03
+60.71%
|
-0.08
|
| Purchase Of PPE |
|
-0.06
-140.00%
|
-0.03
+24.24%
|
-0.03
+60.71%
|
-0.08
|
| Capital Expenditure |
|
-0.06
-140.00%
|
-0.03
+24.24%
|
-0.03
+60.71%
|
-0.08
|
| Net Investment Purchase And Sale |
|
-72.32
-4730.22%
|
1.56
-22.13%
|
2.01
+153.46%
|
-3.75
|
| Purchase Of Investment |
|
-82.93
-1519.65%
|
-5.12
+49.11%
|
-10.06
-168.12%
|
-3.75
|
| Sale Of Investment |
|
10.60
+58.67%
|
6.68
-44.62%
|
12.07
|
0.00
|
| Financing Cash Flow |
|
86.24
+986.69%
|
7.94
+21.01%
|
6.56
+51.67%
|
4.32
|
| Cash Flow From Continuing Financing Activities |
|
86.24
+986.69%
|
7.94
+21.01%
|
6.56
+51.67%
|
4.32
|
| Net Common Stock Issuance |
|
86.24
+986.68%
|
7.94
+21.01%
|
6.56
+51.67%
|
4.32
|
| Proceeds From Stock Option Exercised |
|
0.00
|
0.00
|
—
|
—
|
| Changes In Cash |
|
0.81
+25.39%
|
0.65
+32400.00%
|
-0.00
+99.98%
|
-11.06
|
| Beginning Cash Position |
|
3.16
+25.67%
|
2.52
-0.08%
|
2.52
-81.45%
|
13.58
|
| End Cash Position |
|
3.97
+25.61%
|
3.16
+25.67%
|
2.52
-0.08%
|
2.52
|
| Free Cash Flow |
|
-13.11
-48.06%
|
-8.85
-3.34%
|
-8.57
+26.36%
|
-11.63
|
| Interest Paid Supplemental Data |
|
—
|
—
|
—
|
—
|
| Common Stock Issuance |
|
86.24
+986.68%
|
7.94
+21.01%
|
6.56
+51.67%
|
4.32
|
| Issuance Of Capital Stock |
|
86.24
+986.68%
|
7.94
+21.01%
|
6.56
+51.67%
|
4.32
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-04-22 View
- 8-K2026-04-14 View
- 8-K2026-04-13 View
- 8-K2026-04-10 View
- 42026-04-03 View
- 42026-04-03 View
- 42026-04-03 View
- 42026-04-03 View
- 42026-04-03 View
- 42026-04-03 View
- 10-K2026-03-26 View
- 8-K2026-03-26 View
- 8-K2026-03-24 View
- 8-K2026-03-17 View
- 8-K2026-03-10 View
- 8-K2026-03-04 View
- 8-K2026-03-03 View
- 8-K2026-02-24 View
- 8-K2026-02-24 View
- 42026-02-20 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|